Detalhe da pesquisa
1.
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study.
Gastric Cancer
; 27(1): 118-130, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37906316
2.
MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis.
Proc Natl Acad Sci U S A
; 117(24): 13529-13540, 2020 06 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32482852
3.
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer.
Exp Cell Res
; 409(2): 112930, 2021 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34800542
4.
HER2 Regulates Cancer Stem Cell Activities via the Wnt Signaling Pathway in Gastric Cancer Cells.
Oncology
; 97(5): 311-318, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31550723
5.
Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.
Int J Cancer
; 143(1): 151-159, 2018 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29435981
6.
Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy.
BMC Cancer
; 18(1): 1116, 2018 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30442107
7.
ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer.
Br J Cancer
; 117(12): 1798-1809, 2017 Dec 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29024940
8.
Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.
Ann Surg
; 265(5): 946-953, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27232252
9.
Varlitinib and Paclitaxel for EGFR/HER2 Co-Expressing Advanced Gastric Cancer: a Multicenter Phase Ib/II Study (K-MASTER-13).
Cancer Res Treat
; 2024 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38697849
10.
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study.
J Clin Oncol
; 42(3): 348-357, 2024 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37883723
11.
Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study.
Anticancer Res
; 44(1): 347-359, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38160001
12.
Application of the adjuvant! Online model to Korean breast cancer patients: an assessment of prognostic accuracy and development of an alternative prognostic tool.
Ann Surg Oncol
; 20(8): 2615-24, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23543197
13.
Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer.
BMC Cancer
; 13: 394, 2013 Aug 23.
Artigo
Inglês
| MEDLINE | ID: mdl-23967865
14.
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
Lancet Oncol
; 13(2): 181-8, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22192731
15.
Targeting AXL Using the AVB-500 Soluble Receptor and through Genetic Knockdown Inhibits Bile Duct Cancer Growth and Metastasis.
Cancers (Basel)
; 15(6)2023 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36980768
16.
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer.
J Clin Oncol
; 41(27): 4394-4405, 2023 09 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37364218
17.
Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response.
Cell Rep Med
; 4(11): 101251, 2023 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37890486
18.
Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells.
BMC Genomics
; 13: 348, 2012 Jul 30.
Artigo
Inglês
| MEDLINE | ID: mdl-22846430
19.
A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy.
Invest New Drugs
; 30(4): 1501-10, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21567184
20.
A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer.
Invest New Drugs
; 30(1): 357-63, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20734110